Skip to main content
. 2022 Feb 3;17:69. doi: 10.1186/s13018-022-02968-y

Table 4.

Functional outcomes comparison of the Hepple stage 2 and stage 3 patients of the lesion group

Variable Hepple stage 2 group (n = 32) Hepple stage 3 group (n = 28) PaValue
Operative time, min 50.16 ± 5.89 48.64 ± 7.29 0.378b
Hospital duration, day 3.63 ± 0.61 3.46 ± 0.58 0.300b
VAS 1 yr 0.0 (0.0–.0) 0.0 (0.0–2.0) 0.173c
2 yr 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.225c
AOFAS 1 yr 89.88 ± 4.20 91.75 ± 4.96 0.421b
2 yr 91.31 ± 4.69 92.07 ± 4.23 0.390b
KAFS 1 yr 89.72 ± 4.39 90.61 ± 4.05 0.119b
2 yr 91.56 ± 4.12 90.61 ± 4.43 0.515b
ATT 1 yr 2.34 ± 1.18 2.64 ± 0.99 0.296b
2 yr 2.81 ± 1.23 279 ± 1.07 0.929b
AJPS 1 yr Inversion 10° 7.41 ± 1.27 8.04 ± 1.40 0.073b
1 yr Inversion 20° 17.59 ± 1.76 17.82 ± 1.39 0.584b
1 yr Plantar flexion 10° 7.78 ± 1.13 7.43 ± 1.17 0.240b
1 yr Plantar flexion 20° 18.34 ± 1.18 18.36 ± 1.42 0.968b
2 yr Inversion 10° 7.97 ± 1.68 8.04 ± 1.32 0.865b
2 yr Inversion 20° 17.94 ± 1.65 17.96 ± 1.67 0.950b
2 yr Plantar flexion 10° 8.03 ± 1.20 7.61 ± 1.26 0.188b
2 yr Plantar flexion 20° 18.97 ± 1.12 17.96 ± 1.53 0.006b

VAS, Visual Analogue Scale; AOFAS, American Orthopaedic Foot and Ankle Society; KAFS, Karlsson Ankle Function Score; ATT, Anterior Talar Translation; AJPS, Active Joint Position Sense

aA value p < 0.05 was set as statistically significant

bt test

cMann–Whitney test